This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Should Invesco S&P 500 Revenue ETF (RWL) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for RWL
Should Vanguard Mega Cap Value ETF (MGV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MGV
Dow Jones ETF DIA Getting All Love: Here's Why
by Sanghamitra Saha
Investors are pouring their love into the Dow Jones ETF (DIA). Here's why.
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF
Humana Incurs Wider Y/Y Loss in Q4 on Decline in Membership
by Zacks Equity Research
HUM's fourth-quarter results suffer a blow due to a membership decline in Medicare stand-alone PDP, partly offset by a strong Primary Care business. It currently expects 2025 adjusted EPS to be around $16.25.
Should SPDR Dow Jones Industrial Average ETF (DIA) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DIA
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
by Zacks Equity Research
Sector ETF report for IYH
Dow Jones ETF DIA Outperforms in January: Here's Why
by Sanghamitra Saha
Less tech and high financials exposure helped the Dow Jones ETF stay strong in January.
Centene Q4 Earnings Beat Estimates on Membership Growth, 2025 View Up
by Zacks Equity Research
CNC now projects premium and service revenues of $158-$160 billion in 2025.
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
by Zacks Equity Research
Sector ETF report for XLV
Cigna Q4 Earnings Miss Estimates on Decline in Medical Membership
by Zacks Equity Research
CI's Q4 results reflect a decline in Individual and Family Plans customers. Management expects 2025 adjusted EPS at a minimum of $29.50, which indicates growth of at least 7.9% from the 2024 figure.
Should You Invest in the Vanguard Health Care ETF (VHT)?
by Zacks Equity Research
Sector ETF report for VHT
Is UnitedHealth (UNH) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in UnitedHealth (UNH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
HCA Healthcare's Q4 Earnings Beat Estimates on Strong Admissions
by Zacks Equity Research
HCA's Q4 results benefit from improved equivalent admissions and inpatient surgeries, partly offset by the impact of hurricanes and higher salaries and benefits expenses.
UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The Zacks Analyst Blog Tesla, UnitedHealth Group, Oracle and Earth Science Tech
by Zacks Equity Research
Tesla, UnitedHealth Group, Oracle and Earth Science Tech are included in this Analyst Blog.
Top Research Reports for Tesla, UnitedHealth & Oracle
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Tesla, Inc. (TSLA), UnitedHealth Group Incorporated (UNH) and Oracle Corporation (ORCL), as well as a micro-cap stock Earth Science Tech, Inc. (ETST).
Elevance Health's Q4 Earnings Beat Estimates on Rising Premiums
by Zacks Equity Research
ELV's fourth-quarter results benefit from rising premiums. However, higher expenses and attrition in Medicaid membership partially offset the positives.
Is UnitedHealth a Buy After Q4 Domestic Commercial Membership Growth?
by Kaibalya Pravo Dey
UNH's Optum Health is expected to serve about 5.4 million value-based care patients in 2025.
ETFs in Focus Post UnitedHealth's Mixed Q4 Results
by Sweta Killa
UnitedHealth breezes past the Zacks Consensus Estimate for earnings but misses the same for revenues.
Stock Market News for Jan 17, 2025
by Zacks Equity Research
Wall Street closed lower on Thursday as market participants assessed economic data that signaled a resilient U.S. economy.
Mixed Bag for UnitedHealth: Q4 Earnings Beat, Revenues Fall Short
by Zacks Equity Research
UNH projects revenues between $450 billion and $455 billion for 2025.
UnitedHealth (UNH) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for UnitedHealth (UNH) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Will UNH, HUM & CVS be the Top Beneficiaries of the $21B MA Boom?
by Kaibalya Pravo Dey
The government's payment rate directly impacts insurers' pricing, plan benefits and overall profitability.